Freedom Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Sell |
9,000
-506
| -5% | -$24.6K | 0.03% | 484 |
|
|
2025
Q1 | $323K | Sell |
9,506
-511
| -5% | -$17.4K | 0.03% | 566 |
|
|
2024
Q4 | $394K | Buy |
10,017
+1,856
| +23% | +$73.1K | 0.03% | 497 |
|
|
2024
Q3 | $383K | Sell |
8,161
-428
| -5% | -$20.1K | 0.03% | 515 |
|
|
2024
Q2 | $464K | Buy |
8,589
+2,030
| +31% | +$110K | 0.04% | 447 |
|
|
2024
Q1 | $447K | Sell |
6,559
-1,888
| -22% | -$129K | 0.04% | 474 |
|
|
2023
Q4 | $529K | Buy |
8,447
+78
| +0.9% | +$4.88K | 0.04% | 419 |
|
|
2023
Q3 | $380K | Sell |
8,369
-699
| -8% | -$31.7K | 0.05% | 433 |
|
|
2023
Q2 | $509K | Buy |
9,068
+420
| +5% | +$23.6K | 0.06% | 390 |
|
|
2023
Q1 | $391K | Sell |
8,648
-67
| -0.8% | -$3.03K | 0.04% | 476 |
|
|
2022
Q4 | $354K | Sell |
8,715
-17,722
| -67% | -$720K | 0.04% | 531 |
|
|
2022
Q3 | $1.73M | Buy |
26,437
+13,638
| +107% | +$891K | 0.2% | 125 |
|
|
2022
Q2 | $778K | Sell |
12,799
-5,258
| -29% | -$320K | 0.08% | 311 |
|
|
2022
Q1 | $1.13M | Sell |
18,057
-6,172
| -25% | -$387K | 0.1% | 259 |
|
|
2021
Q4 | $1.84M | Buy |
24,229
+287
| +1% | +$21.7K | 0.13% | 194 |
|
|
2021
Q3 | $2.68M | Buy |
23,942
+2,596
| +12% | +$291K | 0.2% | 116 |
|
|
2021
Q2 | $3.46M | Sell |
21,346
-1,663
| -7% | -$269K | 0.26% | 87 |
|
|
2021
Q1 | $2.8M | Buy |
+23,009
| New | +$2.8M | 0.22% | 104 |
|